Dr. Dvorak is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Beth Israel Deaconess Medical Center
330 Brookline Avenue
Boston, MA 02215Phone+1 617-667-4343- Is this information wrong?
Education & Training
Massachusetts General HospitalResidency, Pathology-Anatomic and Clinical, 1963 - 1965
Harvard Medical SchoolClass of 1963
Certifications & Licensure
MA State Medical License 1964 - 2017- American Board of Pathology Anatomic Pathology
Publications & Presentations
PubMed
- 15 citationsReconciling VEGF With VPF: The Importance of Increased Vascular Permeability for Stroma Formation in Tumors, Healing Wounds, and Chronic InflammationHarold F. Dvorak> ;Frontiers in Cell and Developmental Biology. 2021 Mar 23
- 41 citationsTumors: Wounds That Do Not Heal-A Historical Perspective with a Focus on the Fundamental Roles of Increased Vascular Permeability and Clotting.Harold F. Dvorak> ;Seminars in Thrombosis and Hemostasis. 2019 May 16
- 12 citationsEarly Actions of Anti-Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor Drugs on Angiogenic Blood Vessels.Basel Sitohy, Sung-Hee Chang, Tracey E. Sciuto, Elizabeth M. Masse, Mei Shen, Peter M. Kang, Shou-Ching S. Jaminet, Laura E. Benjamin, Rupal S. Bhatt, Ann M. Dvorak, J...> ;The American Journal of Pathology. 2017 Oct 1
- Join now to see all
Lectures
- 28th Annual Critical Issues in Tumor Microenvironment, Angiogenesis and MetastastasisHarvard Medical School, Cambridge, Massachusetts - 9/30/2013
- 28th Annual Critical Issues in Tumor Microenvironment, Angiogenesis and MetastastasisHarvard Medical School, Cambridge, Massachusetts - 9/30/2013
Press Mentions
2020 Szent-Györgyi Prize Awarded to a Pioneering Researcher Who Has Unlocked Workings of Cancer Drugs of Natural Product OriginFebruary 13th, 2020
New Drug Candidate Is Promising Therapeutic Option for Angiogenic Retinal DiseasesOctober 14th, 2015
Grant Support
- Molecular Dissection Of The Angiogenic Response Induced By VEGF-ANational Cancer Institute2009–2012
- Administrative CoreNational Cancer Institute2009–2012
- Spatial And Temporal Regulation Of AngiogenesisNational Cancer Institute2002–2012
- Vegfs In Tumor Lymphatic MetastasisNational Cancer Institute2009–2011
- Training Program In Angiogenesis &InflammationNational Heart, Lung, And Blood Institute2003–2011
- Adenoviral Vectors For Delivery Of Angiogenic CytokinesNational Heart, Lung, And Blood Institute2001–2008
- Permselective Properties Of Tumor And Wound Blood VesselNational Cancer Institute1989–2004
- Structure And Function Of New Blood VesselsNational Cancer Institute2002
- Training Program In Angiogenesis And InflammationNational Heart, Lung, And Blood Institute1998–2002
- VPF/VEGF In Breast Cancer AngiogenesisNational Heart, Lung, And Blood Institute1995–1998
- Gordon Research--Angiogenesis And MicrocirculationNational Heart, Lung, And Blood Institute1997
- Pathogenesis Of Tumor Stroma Generation &Wound HealingNational Cancer Institute1993–1997
- Biology Of Solid &Ascites Tumor GrowthNational Cancer Institute1988–1992
- Biology Of Solid Tumor Growth And Immune RejectionNational Cancer Institute1985–1989
- Pathogenesis Of Tumor Stroma GenerationNational Cancer Institute1985–1987
Hospital Affiliations
Beth Israel Deaconess Medical CenterBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
